(NASDAQ: CGNX) Cognex's forecast annual revenue growth rate of 7.6% is forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 7.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.49%.
Cognex's revenue in 2026 is $1,088,930,000.On average, 24 Wall Street analysts forecast CGNX's revenue for 2026 to be $190,597,612,986, with the lowest CGNX revenue forecast at $176,803,257,942, and the highest CGNX revenue forecast at $204,560,191,872. On average, 24 Wall Street analysts forecast CGNX's revenue for 2027 to be $207,588,221,028, with the lowest CGNX revenue forecast at $182,691,092,412, and the highest CGNX revenue forecast at $223,401,262,176.
In 2028, CGNX is forecast to generate $229,625,544,330 in revenue, with the lowest revenue forecast at $204,391,968,030 and the highest revenue forecast at $250,317,076,896.